Challenges in managing myeloma patients VJHemOnc – Video Journal of Hematology & HemOnc 0:51 4 years ago 32 Далее Скачать
Welcome address by the Rector, Professor of the School of Medicine, Meletios-Athanasios C Dimopoulos ΕΚΠΑ ΝΚUA 5:49 3 years ago 493 Далее Скачать
STaMINA: Long-term follow-up VJHemOnc – Video Journal of Hematology & HemOnc 1:50 4 years ago 43 Далее Скачать
Imaging modalities and treatment breakthroughs in myeloma bone disease VJHemOnc – Video Journal of Hematology & HemOnc 2:43 5 years ago 101 Далее Скачать
Which is the best combination therapy in relapsed and refractory multiple myeloma? VJHemOnc – Video Journal of Hematology & HemOnc 1:37 7 years ago 188 Далее Скачать
BPd as a new SoC in R/R multiple myeloma based on findings from the DREAMM-8 trial VJHemOnc – Video Journal of Hematology & HemOnc 1:22 3 months ago 72 Далее Скачать
The evolving use of selinexor in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:16 12 days ago 107 Далее Скачать
Belantamab mafodotin: a potential new SoC in second-line myeloma based on the DREAMM trials VJHemOnc – Video Journal of Hematology & HemOnc 0:58 2 months ago 56 Далее Скачать
The impact of an evolving first-line setting on subsequent treatment lines in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 0:40 3 months ago 114 Далее Скачать
Which treatments are currently available for relapsed and refractory myeloma treatment? VJHemOnc – Video Journal of Hematology & HemOnc 1:50 7 years ago 102 Далее Скачать
Initial results of the phase III BOSTON study VJHemOnc – Video Journal of Hematology & HemOnc 1:29 4 years ago 80 Далее Скачать
The use of oral ixazomib maintenance following autoSCT in patients with NDMM VJHemOnc – Video Journal of Hematology & HemOnc 0:43 2 months ago 51 Далее Скачать
The APOLLO trial: daratumumab for R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:28 3 years ago 163 Далее Скачать
First-in-human trial of an anti-BCMA ADC for R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:42 3 years ago 56 Далее Скачать
The CANDOR trial extended follow-up: daratumumab for R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:09 3 years ago 145 Далее Скачать
Dara-VRd in multiple myeloma with high-risk cytogenetics: insights from the PERSEUS trial VJHemOnc – Video Journal of Hematology & HemOnc 1:00 2 months ago 164 Далее Скачать
KdD vs Kd for R/R MM: renal subgroup analysis from CANDOR VJHemOnc – Video Journal of Hematology & HemOnc 0:49 9 months ago 49 Далее Скачать
BelaRd trial: belamaf, lenalidomide, and dex in newly diagnosed MM VJHemOnc – Video Journal of Hematology & HemOnc 1:07 8 months ago 71 Далее Скачать
OPTIMISMM: benefits of a new triplet therapy for MM patients relapsing on lenalidomide VJHemOnc – Video Journal of Hematology & HemOnc 1:43 5 years ago 72 Далее Скачать
Results of the PERSEUS trial: D-VRd with D-R maintenance in transplant-eligible newly diagnosed MM VJHemOnc – Video Journal of Hematology & HemOnc 1:19 9 months ago 306 Далее Скачать
